| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 74.532 | 89.509 | 88.324 | 88.773 | 92.742 | 72.140 | 72.236 | 4.973 | 0 | 0 |
| Total Income - EUR | 74.614 | 89.513 | 88.326 | 88.777 | 92.776 | 75.062 | 112.357 | 4.982 | 0 | 0 |
| Total Expenses - EUR | 53.378 | 66.753 | 65.574 | 73.504 | 73.664 | 67.849 | 72.632 | 10.874 | 5.812 | 586 |
| Gross Profit/Loss - EUR | 21.236 | 22.760 | 22.752 | 15.273 | 19.112 | 7.213 | 39.726 | -5.892 | -5.812 | -586 |
| Net Profit/Loss - EUR | 18.998 | 21.865 | 21.868 | 14.385 | 18.185 | 6.532 | 38.427 | -6.038 | -5.812 | -586 |
| Employees | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 1 | 0 | 0 |
Check the financial reports for the company - Sangvitest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.619 | 35.998 | 32.322 | 22.448 | 35.130 | 27.541 | 12.216 | 7.719 | 3.503 | 2.897 |
| Current Assets | 19.655 | 22.174 | 35.046 | 33.740 | 48.181 | 44.515 | 77.708 | 36.058 | 25.777 | 17.808 |
| Inventories | 367 | 408 | 35 | 0 | 20 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.945 | 2.885 | 1.134 | 1.371 | 2.221 | 1.336 | 2.739 | 5.720 | 17.529 | 12.347 |
| Cash | 17.343 | 18.881 | 33.877 | 32.370 | 45.940 | 43.179 | 74.969 | 30.338 | 8.247 | 5.461 |
| Shareholders Funds | 13.656 | 35.382 | 34.043 | 47.803 | 65.843 | 50.045 | 77.026 | 30.672 | 24.767 | 18.958 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.617 | 22.790 | 33.325 | 8.385 | 16.126 | 22.010 | 12.897 | 13.105 | 4.513 | 1.747 |
| Income in Advance | 0 | 0 | 0 | 0 | 1.341 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sangvitest Srl